Study Details
A Study to Test a Device for People with Blood Clots
(IRB#: IRB_00167854)
The purpose of this study is to learn more about the safety, performance, and clinical benefits of the JETi Hydrodynamic Thrombectomy System. This system is a device used in patients to remove blood clots within a blood vessel. The device is approved by the United States Federal Drug Administration (FDA). Participation in the study will last one year. Participation requires in-person clinic visits at the University of Utah and attending 2 follow-up visits in-person, virtually, or on a phone at the end of the study. Participants are paid $200 at full completion of participation. Participants are paid $200 at full completion of participation.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 18 years and older
- Treated for peripheral thrombosis (having a blood clot in a vein most often in the left and can be in the arm) with the JETi Hydrodynamic Thrombectomy System
Exclusion Criteria
- Currently in another drug or device study
- Previously registered in the JETI registry in the last 12 months unless treated in the contralateral limb/different anatomy such as stroke that may cause the side of the body (leg and/or arm) with limited movement
- COVID symptoms and/or positive test result within the past 20 days of participation
Will I be paid for my time?
Yes
IRB#: IRB_00167854
PI: Benjamin Brooke
Department: Vascular Surgery Division
Approval Date: 2023-08-24 19:30:00
Specialties: Vascular Surgery